Presented by Maria Elena Monzani. The nature and origin of dark matter are among the most compelling mysteries of contemporary science.

The lab is responding to the coronavirus crisis by imaging disease-related biomolecules, developing standards for reliable coronavirus testing and enabling other essential research.

Scientists are deploying this state-of-the-art X-ray crystallography facility to study biological molecules related to the COVID-19 pandemic.

University of Alberta researchers worked with SLAC X-ray scientists to explore the potential of a feline coronavirus drug that may be effective against SARS-CoV-2.

They found that gently heating N95 masks in high relative humidity could inactivate SARS-CoV-2 virus trapped within the masks, without degrading the masks’ performance.

No human cell can function without these tiny machines, which cause disease when they go haywire and offer potential targets for therapeutic drugs.

The center complements other NIH centers at SLAC and elsewhere that broaden access to this cutting-edge technology for biomedical research.

The LSST camera integration and testing team inserted a raft of nine imaging sensors into the body of the ComCam. This miniature version of...

A SLAC/Stanford study of the population of satellite galaxies orbiting the Milky Way provides new clues about the particle nature of dark matter.

The Dark Energy Spectroscopic Instrument begins final testing, setting the stage for a 5-year survey that will analyze the light of 35 million galaxies.

Presented by Eric Charles. A single gamma ray carries millions of times the energy of a single photon of visible light.  This means that...

Presented by Wah Chiu. Cryogenic electron microscopy (cryo-EM) is a revolutionary technology for making 3D images of the inner workings of cells in much...